Cooper Financial Group Abb Vie Inc. Transaction History

Cooper Financial Group

$752 Million
Q3 2024

A detailed history of Cooper Financial Group transactions in Abb Vie Inc. stock. As of the latest transaction made, Cooper Financial Group holds 9,573 shares of ABBV stock, worth $1.68 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

9,573

Previous 12,365 22.58%

Holding current value

$1.68 Million

Previous $2.12 Million 10.85%

% of portfolio

0.25%

Previous 0.32%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $457,441 - $556,529	-2,792 Reduced 22.58%	9,573 $1.89 Million
Q2 2024 Jul 15, 2024	SELL	$154.79 - $180.76 $102,625 - $119,843	-663 Reduced 5.09%	12,365 $2.12 Million
Q1 2024 Apr 11, 2024	BUY	$159.82 - $182.1 $253,634 - $288,992	1,587 Added 13.87%	13,028 $2.37 Million
Q4 2023 Jan 16, 2024	BUY	$137.6 - $154.97 $90,678 - $102,125	659 Added 6.11%	11,441 $1.77 Million
Q3 2023 Oct 13, 2023	SELL	$133.59 - $154.65 $43,550 - $50,415	-326 Reduced 2.93%	10,782 $1.61 Million
Q2 2023 Jul 07, 2023	BUY	$132.51 - $164.9 $94,347 - $117,408	712 Added 6.85%	11,108 $1.5 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $104,408 - $120,241	722 Added 7.46%	10,396 $1.66 Million
Q4 2022 Jan 13, 2023	BUY	$138.31 - $165.87 $336,369 - $403,395	2,432 Added 33.58%	9,674 $0
Q3 2022 Oct 13, 2022	BUY	$134.21 - $153.93 $92,739 - $106,365	691 Added 10.55%	7,242 $972,000
Q2 2022 Jul 11, 2022	BUY	$137.62 - $174.96 $156,473 - $198,929	1,137 Added 21.0%	6,551 $1 Million
Q1 2022 Apr 12, 2022	SELL	$131.98 - $163.75 $39,198 - $48,633	-297 Reduced 5.2%	5,414 $878,000
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $406,300 - $514,087	-3,782 Reduced 39.84%	5,711 $773,000
Q3 2021 Oct 06, 2021	BUY	$106.4 - $120.78 $119,380 - $135,515	1,122 Added 13.4%	9,493 $1.02 Million
Q2 2021 Jul 12, 2021	BUY	$105.21 - $117.21 $178,646 - $199,022	1,698 Added 25.45%	8,371 $943,000
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $466,283 - $513,321	-4,558 Reduced 40.58%	6,673 $722,000
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $390,215 - $526,832	4,848 Added 75.95%	11,231 $1.2 Million
Q3 2020 Oct 09, 2020	BUY	$85.91 - $100.83 $72,078 - $84,596	839 Added 15.13%	6,383 $559,000
Q2 2020 Jul 15, 2020	BUY	$73.37 - $98.18 $25,826 - $34,559	352 Added 6.78%	5,544 $544,000
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $72,627 - $110,111	1,126 Added 27.69%	5,192 $396,000
Q4 2019 Jan 07, 2020	BUY	$72.13 - $90.25 $45,153 - $56,496	626 Added 18.2%	4,066 $360,000
Q3 2019 Oct 08, 2019	BUY	$62.98 - $75.72 $216,651 - $260,476	3,440 New	3,440 $261,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cooper Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Cooper Financial Group with notifications on news.

Account

Cooper Financial Group Abb Vie Inc. Transaction History